Back to Journals » Therapeutics and Clinical Risk Management

SJR OA
CiteScore
Impact Factor

Therapeutics and Clinical Risk Management

ISSN: 1178-203X


       

Journal Articles:


Review

The Etiologic Landscape of Lymphoproliferation in Childhood: Proposal for a Diagnostic Approach Exploring from Infections to Inborn Errors of Immunity and Metabolic Diseases

Costagliola G, De Marco E, Massei F, Roberti G, Catena F, Casazza G, Consolini R

Therapeutics and Clinical Risk Management 2024, 20:261-274

Published Date: 16 May 2024

Review

Unmet needs in asthma

Gruffydd-Jones K

Therapeutics and Clinical Risk Management 2019, 15:409-421

Published Date: 14 March 2019

Review

Choosing the right inhaler for your asthma or COPD patient

Usmani OS

Therapeutics and Clinical Risk Management 2019, 15:461-472

Published Date: 14 March 2019

Review

Clinical efficacy and safety of anticholinergic therapies in pediatric patients

Goldstein S

Therapeutics and Clinical Risk Management 2019, 15:437-449

Published Date: 14 March 2019

Review

Preschool children with persistent asthmatic symptoms

Vogelberg C

Therapeutics and Clinical Risk Management 2019, 15:451-460

Published Date: 14 March 2019

Review

Barriers to achieving asthma control in adults: evidence for the role of tiotropium in current management strategies

Jenkins C

Therapeutics and Clinical Risk Management 2019, 15:423-435

Published Date: 14 March 2019

Review

Future perspectives of anticholinergics for the treatment of asthma in adults and children

Buhl R, Hamelmann E

Therapeutics and Clinical Risk Management 2019, 15:473-485

Published Date: 14 March 2019

Editorial

Anticholinergics in asthma: are we utilizing asthma therapies effectively?

Vogelberg C

Therapeutics and Clinical Risk Management 2019, 15:405-408

Published Date: 14 March 2019